<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04800484</url>
  </required_header>
  <id_info>
    <org_study_id>201811701</org_study_id>
    <nct_id>NCT04800484</nct_id>
  </id_info>
  <brief_title>The Effects of AFO Heel Height and Stiffness on Gait</brief_title>
  <acronym>AFOHeel</acronym>
  <official_title>The Effects of AFO Heel Height and Stiffness on Gait</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study evaluates the effect of ankle foot orthosis (AFO) heel height and&#xD;
      stiffness on the forces and motion of the lower limb during over-ground walking in&#xD;
      individuals who use an AFO for daily walking. Previous studies suggest that heel height and&#xD;
      stiffness effect limb loading, but these data and the analysis techniques applied are&#xD;
      limited. In this study, heel cushions with different height and stiffness's (4 conditions)&#xD;
      will be placed in participants shoes and they will walk at controlled and self-selected&#xD;
      speeds. Participants will also walk with their AFO as configured prior to enrollment, and&#xD;
      with no AFO if possible. The proposed study will provide evidence that can be used by&#xD;
      clinicians and researchers to align braces that most effectively improve function during&#xD;
      every-day walking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators to evaluate the effect of ankle foot orthosis (AFO) heel&#xD;
      height and stiffness on the forces and motion of the lower limb during over-ground walking in&#xD;
      individuals who use an AFO for daily walking. Previous studies suggest that heel height and&#xD;
      stiffness effect limb loading, but these data and the analysis techniques applied are&#xD;
      limited.&#xD;
&#xD;
      Two groups of subjects with impairments below the knee, that result in functional deficits&#xD;
      and require daily AFO use, will be recruited for this study. The first group will have&#xD;
      unilateral deficits associated with musculoskeletal injury or disease (Group 1), and the&#xD;
      second group will have bilateral or unilateral deficits associated with peripheral nervous&#xD;
      system disease (Group 2).&#xD;
&#xD;
      Lower limb forces and body motion will be assessed using computerized motion capture and&#xD;
      force plates in the floor, as individuals walk over-ground. Small reflective markers placed&#xD;
      on the participant's skin and force measuring plates in the floor will be used. Participants&#xD;
      will walk with their clinically provided AFO, with added heel cushions of two different&#xD;
      heights and stiffness's (4 conditions) at a controlled velocity and self-selected velocity.&#xD;
      If able, they will walk without their AFO at a self-selected pace. Participants will be asked&#xD;
      to provide information regarding their health condition and opinions of the conditions&#xD;
      tested.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will be evaluated in their clinically configured AFO and without an AFO if able. They will also complete evaluation with four provided heel wedge conditions in randomized order: tall soft, tall firm, short soft, short firm.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will be blinded to the heel wedge conditions.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Ankle Range of Motion</measure>
    <time_frame>Baseline</time_frame>
    <description>Ankle range of motion (degrees) during gait.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Ankle Moment</measure>
    <time_frame>Baseline</time_frame>
    <description>Peak ankle moment (Nm/kg) during gait.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Ankle Power</measure>
    <time_frame>Baseline</time_frame>
    <description>Peak ankle power (W/kg) during gait.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Center of pressure velocity timing</measure>
    <time_frame>Baseline</time_frame>
    <description>Timing of peak center of pressure velocity (percent stance) during gait.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Center of pressure velocity magnitude</measure>
    <time_frame>Baseline</time_frame>
    <description>Magnitude of peak center of pressure velocity (m/s) during gait.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Socket Comfort Score (Comfort and Smoothness)</measure>
    <time_frame>Baseline</time_frame>
    <description>Comfort scores range from 0 = most uncomfortable to 10 = most comfortable, and from 0 = least smooth to 10 = most smooth.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Activities-Specific Balance Confidence (ABC)</measure>
    <time_frame>Baseline</time_frame>
    <description>The ABC provides a standardized evaluation of balance confidence across a range of common daily tasks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Patient reported outcomes for physical function</measure>
    <time_frame>Baseline</time_frame>
    <description>The Patient Reported Outcome Information System (PROMIS) physical function Computer Adaptive Test (CAT) is a computerized assessment measuring physical function. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents more of the measured variable than the population average.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant wedge preference</measure>
    <time_frame>Baseline</time_frame>
    <description>The participant will rank order their preference for their Clinical AFO, Tall Soft, Tall Firm, Short Soft, or Short Firm wedge on a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Pain Rating Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable.</description>
  </secondary_outcome>
  <number_of_arms>24</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Musculoskeletal Injury</condition>
  <condition>Musculoskeletal Diseases</condition>
  <condition>Peripheral Nervous System Diseases</condition>
  <arm_group>
    <arm_group_label>Arm 1:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Soft, Tall Firm, Short Soft, Short Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Soft, Tall Firm, Short Firm, Short Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Soft, Short Soft, Tall Firm, Short Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Soft, Short Soft, Short Firm, Tall Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 5:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Soft, Short Firm, Tall Firm, Short Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 6:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Soft, Short Firm, Short Soft, Tall Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 7:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Firm, Tall Soft, Short Soft, Short Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 8:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Firm, Tall Soft, Short Firm, Short Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 9:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Firm, Short Soft, Tall Soft, Short Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 10:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Firm, Short Soft, Short Firm, Tall Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 11:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Firm, Short Firm, Tall Soft, Short Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 12:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Tall Firm, Short Firm, Short Soft, Tall Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 13:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Soft, Tall Soft, Short Firm, Tall Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 14:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Soft, Tall Soft, Tall Firm, Short Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 15:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Soft, Tall Firm, Short Firm, Tall Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 16:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Soft, Tall Firm, Tall Soft, Short Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 17:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Soft, Short Firm, Tall Soft, Tall Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 18:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Soft, Short Firm, Tall Firm, Tall Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 19:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Firm, Tall Soft, Tall Firm, Short Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 20:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Firm, Tall Soft, Short Soft, Tall Firm, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 21:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Firm, Tall Firm, Short Soft, Tall Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 22:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Firm, Tall Firm, Tall Soft, Short Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 23:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Firm, Short Soft, Tall Firm, Tall Soft, NoAFO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 24:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Testing Order: Clinical AFO, Short Firm, Short Soft, Tall Soft, Tall Firm, NoAFO</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tall Soft</intervention_name>
    <description>Tall heel wedge made of soft foam</description>
    <arm_group_label>Arm 10:</arm_group_label>
    <arm_group_label>Arm 11:</arm_group_label>
    <arm_group_label>Arm 12:</arm_group_label>
    <arm_group_label>Arm 13:</arm_group_label>
    <arm_group_label>Arm 14:</arm_group_label>
    <arm_group_label>Arm 15:</arm_group_label>
    <arm_group_label>Arm 16:</arm_group_label>
    <arm_group_label>Arm 17:</arm_group_label>
    <arm_group_label>Arm 18:</arm_group_label>
    <arm_group_label>Arm 19:</arm_group_label>
    <arm_group_label>Arm 1:</arm_group_label>
    <arm_group_label>Arm 20:</arm_group_label>
    <arm_group_label>Arm 21:</arm_group_label>
    <arm_group_label>Arm 22:</arm_group_label>
    <arm_group_label>Arm 23:</arm_group_label>
    <arm_group_label>Arm 24:</arm_group_label>
    <arm_group_label>Arm 2:</arm_group_label>
    <arm_group_label>Arm 3:</arm_group_label>
    <arm_group_label>Arm 4:</arm_group_label>
    <arm_group_label>Arm 5:</arm_group_label>
    <arm_group_label>Arm 6:</arm_group_label>
    <arm_group_label>Arm 7:</arm_group_label>
    <arm_group_label>Arm 8:</arm_group_label>
    <arm_group_label>Arm 9:</arm_group_label>
    <other_name>TS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tall Firm</intervention_name>
    <description>Tall heel wedge made of firm foam</description>
    <arm_group_label>Arm 10:</arm_group_label>
    <arm_group_label>Arm 11:</arm_group_label>
    <arm_group_label>Arm 12:</arm_group_label>
    <arm_group_label>Arm 13:</arm_group_label>
    <arm_group_label>Arm 14:</arm_group_label>
    <arm_group_label>Arm 15:</arm_group_label>
    <arm_group_label>Arm 16:</arm_group_label>
    <arm_group_label>Arm 17:</arm_group_label>
    <arm_group_label>Arm 18:</arm_group_label>
    <arm_group_label>Arm 19:</arm_group_label>
    <arm_group_label>Arm 1:</arm_group_label>
    <arm_group_label>Arm 20:</arm_group_label>
    <arm_group_label>Arm 21:</arm_group_label>
    <arm_group_label>Arm 22:</arm_group_label>
    <arm_group_label>Arm 23:</arm_group_label>
    <arm_group_label>Arm 24:</arm_group_label>
    <arm_group_label>Arm 2:</arm_group_label>
    <arm_group_label>Arm 3:</arm_group_label>
    <arm_group_label>Arm 4:</arm_group_label>
    <arm_group_label>Arm 5:</arm_group_label>
    <arm_group_label>Arm 6:</arm_group_label>
    <arm_group_label>Arm 7:</arm_group_label>
    <arm_group_label>Arm 8:</arm_group_label>
    <arm_group_label>Arm 9:</arm_group_label>
    <other_name>TF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Short Soft</intervention_name>
    <description>Short heel wedge made of soft foam</description>
    <arm_group_label>Arm 10:</arm_group_label>
    <arm_group_label>Arm 11:</arm_group_label>
    <arm_group_label>Arm 12:</arm_group_label>
    <arm_group_label>Arm 13:</arm_group_label>
    <arm_group_label>Arm 14:</arm_group_label>
    <arm_group_label>Arm 15:</arm_group_label>
    <arm_group_label>Arm 16:</arm_group_label>
    <arm_group_label>Arm 17:</arm_group_label>
    <arm_group_label>Arm 18:</arm_group_label>
    <arm_group_label>Arm 19:</arm_group_label>
    <arm_group_label>Arm 1:</arm_group_label>
    <arm_group_label>Arm 20:</arm_group_label>
    <arm_group_label>Arm 21:</arm_group_label>
    <arm_group_label>Arm 22:</arm_group_label>
    <arm_group_label>Arm 23:</arm_group_label>
    <arm_group_label>Arm 24:</arm_group_label>
    <arm_group_label>Arm 2:</arm_group_label>
    <arm_group_label>Arm 3:</arm_group_label>
    <arm_group_label>Arm 4:</arm_group_label>
    <arm_group_label>Arm 5:</arm_group_label>
    <arm_group_label>Arm 6:</arm_group_label>
    <arm_group_label>Arm 7:</arm_group_label>
    <arm_group_label>Arm 8:</arm_group_label>
    <arm_group_label>Arm 9:</arm_group_label>
    <other_name>SS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Short Firm</intervention_name>
    <description>Short heel wedge made of firm foam</description>
    <arm_group_label>Arm 10:</arm_group_label>
    <arm_group_label>Arm 11:</arm_group_label>
    <arm_group_label>Arm 12:</arm_group_label>
    <arm_group_label>Arm 13:</arm_group_label>
    <arm_group_label>Arm 14:</arm_group_label>
    <arm_group_label>Arm 15:</arm_group_label>
    <arm_group_label>Arm 16:</arm_group_label>
    <arm_group_label>Arm 17:</arm_group_label>
    <arm_group_label>Arm 18:</arm_group_label>
    <arm_group_label>Arm 19:</arm_group_label>
    <arm_group_label>Arm 1:</arm_group_label>
    <arm_group_label>Arm 20:</arm_group_label>
    <arm_group_label>Arm 21:</arm_group_label>
    <arm_group_label>Arm 22:</arm_group_label>
    <arm_group_label>Arm 23:</arm_group_label>
    <arm_group_label>Arm 24:</arm_group_label>
    <arm_group_label>Arm 2:</arm_group_label>
    <arm_group_label>Arm 3:</arm_group_label>
    <arm_group_label>Arm 4:</arm_group_label>
    <arm_group_label>Arm 5:</arm_group_label>
    <arm_group_label>Arm 6:</arm_group_label>
    <arm_group_label>Arm 7:</arm_group_label>
    <arm_group_label>Arm 8:</arm_group_label>
    <arm_group_label>Arm 9:</arm_group_label>
    <other_name>SF</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        GROUP 1 Patient Inclusion criteria&#xD;
&#xD;
          -  Ages: 18-70&#xD;
&#xD;
          -  Daily AFO use to address unilateral, below knee functional deficits that result from&#xD;
             limb injury or musculoskeletal disease (e.g. fracture, muscle and/or nerve injury,&#xD;
             ankle arthritis)&#xD;
&#xD;
          -  Greater than 2 weeks using their current AFO&#xD;
&#xD;
          -  Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.)&#xD;
&#xD;
          -  Ability to walk at a slow to moderate pace&#xD;
&#xD;
          -  AFO fits into traditional footwear&#xD;
&#xD;
          -  Able to read and write in English and provide written informed consent&#xD;
&#xD;
        GROUP 1 Patient Exclusion criteria&#xD;
&#xD;
          -  Pain &gt; 6/10 while walking during testing or an increase in pain during testing of &gt;&#xD;
             2/10.&#xD;
&#xD;
          -  Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord&#xD;
             Injury, or other conditions that result in lower limb spasticity).&#xD;
&#xD;
          -  Disorder or disease that affects peripheral nerve function (e.g. diabetes, Charcot&#xD;
             Marie Tooth).&#xD;
&#xD;
          -  Limited contralateral lower limb function due to injury or&#xD;
             neurological/musculoskeletal disorder.&#xD;
&#xD;
          -  Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop,&#xD;
             free motion), Charcot Restraint Orthotic Walker (CROW) boot, AFOs that restrict all&#xD;
             motion in the ankle and foot.&#xD;
&#xD;
          -  Use of an AFO that crosses the knee (Knee brace)&#xD;
&#xD;
          -  Insufficient space in shoe to accommodate the tallest heel wedge and their AFO&#xD;
&#xD;
          -  Visual or hearing impairments that limit walking ability or could limit the ability to&#xD;
             comply with instructions given during testing&#xD;
&#xD;
          -  Pregnancy - Per participant self-report. Due the expected small number of pregnant&#xD;
             individuals, and resulting inability to account for its effect on resulting outcomes&#xD;
             participants will be withdrawn from the study.&#xD;
&#xD;
          -  Body Mass index &gt; 40.&#xD;
&#xD;
        GROUP 2 Patient Inclusion Criteria&#xD;
&#xD;
          -  Ages: 18-70&#xD;
&#xD;
          -  Daily AFO use to address below knee functional deficits that result from disease&#xD;
             involving the peripheral nervous system (e.g. Charcot Marie Tooth, Multiple Sclerosis,&#xD;
             diabetes)&#xD;
&#xD;
          -  Greater than 2 weeks using their current AFO (unilateral or bilateral)&#xD;
&#xD;
          -  Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.)&#xD;
&#xD;
          -  AFO fits into traditional footwear&#xD;
&#xD;
          -  Ability to walk at a slow to moderate pace&#xD;
&#xD;
          -  Able to read and write in English and provide written informed consent&#xD;
&#xD;
        GROUP 2 Patient Exclusion Criteria&#xD;
&#xD;
          -  Pain &gt; 6/10 while walking or an increase in pain during testing of &gt; 2/10&#xD;
&#xD;
          -  Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord&#xD;
             Injury, or other conditions that result in lower limb spasticity)&#xD;
&#xD;
          -  Limited function due to limb injury (e.g. fracture, muscle and/or nerve injury)&#xD;
&#xD;
          -  Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop,&#xD;
             free motion), Charcot Restraint Orthotic Walker (CROW) boot, AFOs that restrict all&#xD;
             motion in the ankle and foot.&#xD;
&#xD;
          -  Use of an AFO that crosses the knee (Knee brace)&#xD;
&#xD;
          -  Insufficient space in shoe to accommodate the tallest heel wedge and their AFO&#xD;
&#xD;
          -  Visual or hearing impairment that limit walking ability or limit the ability to comply&#xD;
             with instructions given during testing&#xD;
&#xD;
          -  Pregnancy - Per participant self-report. Due the expected small number of pregnant&#xD;
             individuals, and resulting inability to account for its effect on resulting outcomes&#xD;
             participants will be withdrawn from the study&#xD;
&#xD;
          -  Body Mass index &gt; 40.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason M Wilken, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jason M Wilken, PT, PhD</last_name>
    <phone>319-335-6857</phone>
    <email>jason-wilken@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kirsten M Anderson, BSE</last_name>
    <phone>319-353-0431</phone>
    <email>kirsten-m-anderson@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason M Wilken, PT, PhD</last_name>
      <phone>319-335-6857</phone>
      <email>Jason-wilken@uiowa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kirsten M Anderson, BSE</last_name>
      <phone>319-353-0431</phone>
      <email>kirsten-m-anderson@uiowa.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jason M Wilken, PT, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Molly Pacha, MS, ATC, LAT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Jason Wilken</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Gait Analysis</keyword>
  <keyword>Ankle Foot Orthosis</keyword>
  <keyword>Biomechanics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

